Brady Dale (Author of Front Stage Exit) joins Host Ron Steslow to examine the booming gray market for therapeutic peptides and what it reveals about medical freedom, institutional trust, and our resistance to the unfamiliar.
They begin with the market itself, which Brady compares to the early crypto era he covered: people eager to risk their own money against regulators in the way.
Next, they examine the cultural backlash, the moralism that casts GLP-1 weight loss as cheating, and a MAHA coalition at once wary of pharma yet drawn to gray-market compounds.
Then, they turn to safety, where Brady argues the real hazard lies not in the peptides, but in contaminated manufacturing and careless injection. They also weigh the trouble of funding trials for compounds no one can patent.
Finally, they consider bodily autonomy and whether medicine should restore a baseline health or enhance it.
Don’t miss out. Be the first to know about upcoming guests, special events, and more as we continue to build Politicology.